vergentbio.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.vergentbio.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change | ||
Meta Tags
| Title | HOME | Vergent Bioscience | Tumor |
| Description | CANCER SURGERY IN A NEW Vergent Bioscience’s lead compound, VGT-309, is a tumor-targeted fluorescent imaging agent intentionally designed to enable surgeons to see previously undetected or difficult-to-find tumors during surgery in real-time, ensuring all tumor tissue is |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.49.23.144 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
vergentbio.com Valuation
|
US$1,301,316
Last updated: 2023-05-09 00:18:58
vergentbio.com has Semrush global rank of 8,133,541. vergentbio.com has an estimated worth of US$ 1,301,316, based on its estimated Ads revenue. vergentbio.com receives approximately 150,152 unique visitors each day. Its web server is located in United States, with IP address 198.49.23.144. According to SiteAdvisor, vergentbio.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,301,316 |
| Daily Ads Revenue | US$1,202 |
| Monthly Ads Revenue | US$36,037 |
| Yearly Ads Revenue | US$432,438 |
| Daily Unique Visitors | 10,011 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| vergentbio.com. | A | 600 | IP: 198.49.23.144 |
| vergentbio.com. | A | 600 | IP: 198.49.23.145 |
| vergentbio.com. | A | 600 | IP: 198.185.159.144 |
| vergentbio.com. | A | 600 | IP: 198.185.159.145 |
| vergentbio.com. | NS | 3600 | NS Record: ns04.domaincontrol.com. |
| vergentbio.com. | NS | 3600 | NS Record: ns03.domaincontrol.com. |
| vergentbio.com. | MX | 3600 | MX Record: 0 vergentbio-com.mail.protection.outlook.com. |
| vergentbio.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-09 00:18:58
| top of page Our Technology Overview Publications Therapeutic Focus Overview Clinical Summary About Us Overview Our People Investors News Media Contact Contact Us General Inquiries CANCER SURGERY IN A NEW LIGHT Tumor-targeted agents to help surgeons realize the full potential of minimally invasive and robotic-assisted cancer surgery Re-Imagining Tumor Visualization Vergent Bioscience is a clinical-stage biotechnology company that is helping surgeons realize the full potential of minimally invasive and robotic-assisted surgery by improving the visibility of tumors. Vergent’s lead compound, VGT-309 , is a tumor-targeted fluorescent imaging agent intentionally designed to enable surgeons to see previously undetected or difficult-to-find tumors during surgery in real-time, ensuring all tumor tissue is removed. The company is first evaluating VGT-309 in lung cancer , with the potential to expand its application to a wide range of solid tumors . Optimizing surgery as a first-line treatment |
HTTP Headers
HTTP/1.1 301 Moved Permanently Age: 97123 Date: Fri, 29 Oct 2021 19:48:25 GMT Location: https://www.vergentbio.com/ Server: Squarespace Set-Cookie: crumb=BWEIwN06qMPRNGMwMjRlYzU4OGNlZjMzYTBlMDUwYmNjYmZiZDYw;Path=/ X-Contextid: Ucs0mLLS/iRPNZroN HTTP/2 200 accept-ranges: bytes age: 114262 content-type: text/html;charset=utf-8 date: Fri, 29 Oct 2021 15:02:45 GMT etag: W/"64e86924aa7f356fd38ae11f00628650" expires: Thu, 01 Jan 1970 00:00:00 GMT last-modified: Fri, 29 Oct 2021 15:02:45 GMT server: Squarespace set-cookie: crumb=BaKTAmg7aHl4MzkwMzMyMDY1ODk1OTg1MjIzOThjMjc1MTViYjg2;Path=/ strict-transport-security: max-age=0 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: nHKFZxN7/mRjQi875 content-length: 12286 |
vergentbio.com Whois Information
Domain Name: VERGENTBIO.COM Registry Domain ID: 1953896090_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-08-19T15:27:29Z Creation Date: 2015-08-18T20:43:10Z Registry Expiry Date: 2022-08-18T20:43:10Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS03.DOMAINCONTROL.COM Name Server: NS04.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T09:08:11Z <<< |